Meiji Seika Pharma Invests in MPM BioImpact’s New Technologies and Virology Strategy - Business Wire

Meiji Seika Pharma Invests in MPM BioImpact’s New Technologies and Virology Strategy  Business Wire

Meiji Seika Pharma files suit against lawmaker over 'unfounded' vaccine claims - The Japan Times

Meiji Seika Pharma files suit against lawmaker over 'unfounded' vaccine claims  The Japan Times

Meiji Seika Pharma Files Lawsuit In Japan Over Kostaive Misinformation - insights.citeline.com

Meiji Seika Pharma Files Lawsuit In Japan Over Kostaive Misinformation  insights.citeline.com

Meiji Seika Pharma Announces Investment in ARCALIS, Inc. - Business Wire

Meiji Seika Pharma Announces Investment in ARCALIS, Inc.  Business Wire

Japan's Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics' Updated Sel...

Japan's Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics' Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma  PR Newswire

Meiji Seika Pharma Opens New Office in Boston Area to Pursue Investment Opportunities in Innovati...

Meiji Seika Pharma Opens New Office in Boston Area to Pursue Investment Opportunities in Innovative Drugs and Technologies  Yahoo Finance

Meiji Seika Pharma: Announcement of the Establishment of Local Subsidiary "Taiwan Meiji Pharma Co...

Meiji Seika Pharma: Announcement of the Establishment of Local Subsidiary "Taiwan Meiji Pharma Co., Ltd." in Taiwan  Business Wire

Meiji Seika Pharma to supply Japan with self-amplifying mRNA Covid-19 vaccine in fall/winter of 2...

Meiji Seika Pharma to supply Japan with self-amplifying mRNA Covid-19 vaccine in fall/winter of 2024  Endpoints News

Osivax secures strategic funding from Meiji Seika - The Pharma Letter

Osivax secures strategic funding from Meiji Seika  The Pharma Letter

Meiji Seika Pharma Receives Approval for Adding Domestic Manufacturing Sites in Japan for KOSTAIV...

Meiji Seika Pharma Receives Approval for Adding Domestic Manufacturing Sites in Japan for KOSTAIVE®, a Self-amplifying mRNA Vaccine Against COVID-19  BioSpace

Japan's Meiji Seika to build $20.1M manufacturing plant in India - Fierce Pharma

Japan's Meiji Seika to build $20.1M manufacturing plant in India  Fierce Pharma

CSL, Arcturus get first approval for self-assembling RNA jab - pharmaphorum

CSL, Arcturus get first approval for self-assembling RNA jab  pharmaphorum

Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility - Co...

Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility  Contract Pharma

Drug company sues lawmaker over ‘bioweapon’ claim on vaccine - 朝日新聞

Drug company sues lawmaker over ‘bioweapon’ claim on vaccine  朝日新聞

Meiji Seika Pharma: Adcock Ingram Pharma Private Limited Completes Construction of a New Manufact...

Meiji Seika Pharma: Adcock Ingram Pharma Private Limited Completes Construction of a New Manufacturing Facility in India to Enhance its CMO Business  Business Wire

Meiji Seika Pharma: Adcock Ingram Ltd. in India to Build a New Manufacturing Facility to Enhance ...

Meiji Seika Pharma: Adcock Ingram Ltd. in India to Build a New Manufacturing Facility to Enhance Its CMO Business  Business Wire

Osivax Secures Strategic Funding to Accelerate the Development of its Influenza Vaccine Candidate...

Osivax Secures Strategic Funding to Accelerate the Development of its Influenza Vaccine Candidates  Business Wire

Meiji Seika Pharma Sets up a New Subsidiary in the US - Business Wire

Meiji Seika Pharma Sets up a New Subsidiary in the US  Business Wire

AstraZeneca taps JCR Pharmaceuticals, Daiichi Sankyo and other local pharmas to supply COVID-19 s...

AstraZeneca taps JCR Pharmaceuticals, Daiichi Sankyo and other local pharmas to supply COVID-19 shots to Japan  Fierce Pharma

Meiji Seika Pharma invests in ARCALIS to boost production of mRNA vaccines in Japan - BioSpectrum...

Meiji Seika Pharma invests in ARCALIS to boost production of mRNA vaccines in Japan  BioSpectrum Asia

Japan's Meiji Seika Pharma expands CMO business in India - BioSpectrum Asia

Japan's Meiji Seika Pharma expands CMO business in India  BioSpectrum Asia

Meiji Seika Pharma to build new facility in Bangalore to expand CMO business - Indian Pharma Post

Meiji Seika Pharma to build new facility in Bangalore to expand CMO business  Indian Pharma Post

Meiji Seika Pharma teams with lab to research hair loss cure - Nikkei Asia

Meiji Seika Pharma teams with lab to research hair loss cure  Nikkei Asia